Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

radionuclide therapy

  • You have access
    Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide 131I-BA52
    Walter Mier, Clemens Kratochwil, Jessica C. Hassel, Frederik L. Giesel, Barbro Beijer, John W. Babich, Matthias Friebe, Michael Eisenhut, Alexander Enk and Uwe Haberkorn
    Journal of Nuclear Medicine January 1, 2014, 55 (1) 9-14; DOI: https://doi.org/10.2967/jnumed.112.112789
  • You have access
    Long-Term Outcome and Toxicity After Dose-Intensified Treatment with 131I-MIBG for Advanced Metastatic Carcinoid Tumors
    Samer Ezziddin, Amir Sabet, Timur Logvinski, Khaled Alkawaldeh, Charlotte J. Yong-Hing, Hojjat Ahmadzadehfar, Frank Grünwald and Hans-Jürgen Biersack
    Journal of Nuclear Medicine December 1, 2013, 54 (12) 2032-2038; DOI: https://doi.org/10.2967/jnumed.112.119313
  • You have access
    Comparative Analysis of Transcriptional Gene Regulation Indicates Similar Physiologic Response in Mouse Tissues at Low Absorbed Doses from Intravenously Administered 211At
    Britta Langen, Nils Rudqvist, Toshima Z. Parris, Emil Schüler, Khalil Helou and Eva Forssell-Aronsson
    Journal of Nuclear Medicine June 1, 2013, 54 (6) 990-998; DOI: https://doi.org/10.2967/jnumed.112.114462
  • You have access
    DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted 177Lu-Radionuclide Tumor Therapy in Mice
    Cristina Müller, Harriet Struthers, Christian Winiger, Konstantin Zhernosekov and Roger Schibli
    Journal of Nuclear Medicine January 1, 2013, 54 (1) 124-131; DOI: https://doi.org/10.2967/jnumed.112.107235
  • You have access
    A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β−-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative
    Cristina Müller, Konstantin Zhernosekov, Ulli Köster, Karl Johnston, Holger Dorrer, Alexander Hohn, Nico T. van der Walt, Andreas Türler and Roger Schibli
    Journal of Nuclear Medicine December 1, 2012, 53 (12) 1951-1959; DOI: https://doi.org/10.2967/jnumed.112.107540

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire